Clyde Markowitz From University of Pennsylvania: Moving Multiple Sclerosis Treatment Forward for All

Video

It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.

It was not that long ago when doctors would sometimes not discuss the diagnosis of multiple sclerosis with their patients. Now not only is it a condition they can diagnose but treatment is also progressing by leaps and bounds.

Clyde E. Markowitz, MD, from the University of Pennsylvania discussed a recent course given to new members of the field ahead of the annual meeting of the Consortium of Multiple Sclerosis Care Centers during a recent interview with MD Magazine. Markowitz said doctors entering the field now are considerably further ahead in their treatment options for patients than those that came before them and should see even more development in the field before their time is done.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.